Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai,...

49
Mesenchymal Stem/Progenito r cells for Therapeutic an d Tissue engineering appli cations Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences Taipei Medical University

Transcript of Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai,...

Page 1: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineer

ing applications

Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih)

Grad. Inst. Medical SciencesTaipei Medical University

Page 2: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Stem/Progenitor CellsStem cells• Self Renew (Proliferation)• Muti-differentiation potential (Plasticity) :

Trans-differentiation, Transformation, De-differentiation

Progenitor cells• Functional Undetermined Tissue-cell Precu

sors.• Muti-differentiation potential (Plasticity)

Page 3: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 4: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 5: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Types of Stem Cells

– ES Cells (ESCs) [Derived from Embryo inner mass]

– EG Cells (EGCs) [Derived from Fetus gonad]

– Somatic Tissue Stem /Progenitor Cells [ Isolated from Fetus, Neo-natal and Adult Tissues] (tSC, tS/PC): e.g. Neural SCs, Mesenchymal Stem/Progenitor Cells (MSC, MSCs/MPCs), Hemapoietic Stem/Progenitor Cells (HSC, HSCs/HPCs), and Karotinocytes etc.

Page 6: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Development of the Human Preimplantation Blastocyst

Page 7: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Development of Human Embryonic Tissues

Page 8: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 9: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 10: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 11: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

The Niche The Niche Determines The Fate Determines The Fate

of Stem Cellsof Stem CellsEcologic/Epigenetical Microenvironment of Stem Ce

lls

Page 12: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Tissue Stem Cells (tSCs)

Develop & Maintain within Specific Niche

A. Epidermal---Basal Layer

Hair Folocale & Epidermis--- The bulge (Tcf3)

B. Small Intestine--- The crypt Cells ( Tcf4)

C. Neural Precursors Cells--- Ependymal or the Sub Ventricular Zone Cells (AP)

D. Hematopoietic SCs--- Bone Marrow

Page 13: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 14: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 15: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Tissue Maintenance and Repair

• I) Tissue Stem/Progenitor Cells

• II) Environmental Cellular Metrix (ECM)

• III) Associate Stroma Cells

• IV) Cytokines

Page 16: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Basic Requirements for Tissue Regeneration

*Tissue Stem/Progenitor Cells

*Stromal Cells for MicroEnvironmental Support of the Tissue Survival and Normal Functioning.

*Cytokines (Autokine & Parakines) & Chemokines

*Oxygen Supply: Red Blood Cells and Neovascularization

*Sensory Nuron: nurogenesis.

Page 17: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Adapted from speech of Dr. Bruce A. Mast, M.D.: The Regulation of Wound Healing. Division of Plastic and Reconstructive Surgery Department of Surgery Univeristy of Florida. (http://www.medinfo.ufl.edu/cme/grounds/mast/index.html).

Wound Healing

Page 18: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

CD34+ HS/PCs Functions:

Hematopoietic Reconstitution

Immunotherapy

Neovasculogenesis, Neurogenesis, &Tissue Regenerations etc.

Page 19: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 20: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 21: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Comparative analysis of the similar stem cell populations from various origins

Page 22: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

The Niche of HSCs

Marrow(MSC & ECM)

& Soluble Factors

Page 23: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Tissue Mesenchymal Stem Cells

▪ Connective tissue / stromal source

EX : Bone marrow /Adipose tissue / Skin / Muscle

▪ Umbilical cord blood

Definition:

Sites :

▪Mesenchymal Multi-lineage differentiation potential▪Cell surface antigens expression : SH2/SH4/CD105

Page 24: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Bone Marrow Mesenchymal stem cells ( BM-MSCs )

Multipotent differentiation

Interact & Support tissue cells

(mesoderm-derived tissue cell type) : adipocyte / osteoblast / chondrocyte / myoblast / endothelial cell

(Ectoderm) : Neural cells

Hematopoiesis and angiogenesis

Page 25: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Hypotheses to explain the generation of nonhematopoietic tissues from HSC-enriched populations. Totipotential cells derived from the embryo could persist into adult life and be sequestered in the bone marrow, where they could form a reservoir of precursors from which definitive HSCs could develop. Protocols for the enrichment of HSCs based on their phenotypic and physical properties might also result in the isolation of these totipotent cells, which in turn contribute to skeletal or cardiac muscle or cells of the gastrointestinal tract after various transplantation protocols. Alternatively, precursors whose developmental potential is more limited might also be present in the bone marrow. Finally, a pluripotent HSC (PHSC) may be able to alter its genome and transdifferentiate.

Page 26: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 27: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Stem cells find their niche

Page 28: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

NATURE|VOL 428 |11 MARCH 2004|

Creation of long-lasting blood vessels

Page 29: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Gene expression profiling of BM-MSCs

Undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Tremain,N.2001 / Woodbury,D.2002 / eshi,B.2003

Multipotent :

Growth factors / Matrix proteins / Cell surface molecules :

BM-MSCs expressed various kinds of growth factors,matrix proteins, and cell surface molecules. Silva,W.A.,Jr2003

Page 30: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Adipose tissue Mesenchymal stem cells (AD-MSCs)

• Similar to Bone marrow mesenchymal stem cells

CD marker antigens

Multipotent differentiation ▪▪

Page 31: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

A Study on Human Tissue Stem/progenitor cells for Medical Application and Drug Discovery

• Bone Marrow• Placental and

Peripheral Blood• Fat Tissue• Scalp• Amnoitic tissue• Fore Skin• Placenta • Teeth

Page 32: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Stem Cell Isolation and Processing

a. Hematopoietic Stem Cells (HSCs) and Mesodermal Progenitor Cells (MPCs)

MACS

FACS CD34+ cells (HSCs)MNC CD45-GlyA- cells (MPCs)

Page 33: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

c. Processed Lipoaspirate (PLA)

Adherent cells -PLA

Page 34: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Cell surface antigens expression

Multi-lineage differentiation abilities

How to distinguish tissue stem cells ?

Page 35: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Hypothesis: Mesenchymal stem cells in different tissues have their own specific potentials in maintenance of their tissue specific niche

Objective : To understand the tissue MSC specificity for better stem cell therapy applications

Is There Specific Niche for Each Type of Tissue Stem/Progenitor Cells in Human?

Page 36: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

By Combining Cellular and Molecular Characterizations of MSCs derived from

Different Tissues in Human, ….

How Specific Are Tissue Niche Need?

Page 37: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Strategy :

Comparative analysis gene profiling and functional gene characterization

Highly differential expression genes

Cytokines and growth factors genes

Multi-lineage differentiation related genes

Target gene expression

Early gene expressions

Confirm the protein products

Page 38: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Functional genomic characterization

ostogenic / chondrogenic / adipogenic /myogenic / neurongenic /

endothelial cell differentiation

Part 1. Multi-lineage differentiation related genes

Page 39: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Molecular Analytic results suggest that BM-MSCs preferentially expressed functional genes differences from AD-MSCs in:

•Secretion of Hemagiogenic factors (LIF / Jagged-1/ BMP-4 / HGF / PIGF-1 / PIGF-2

/ HB-EGF ),

•Supply Homing/ mobilzing elements (:CD106(VCAM-1)/ jagged-1/ SDF-1), and

•Generation of ECM remodeling factors (mmp9/mmp1) for HS/PCs (CD34+, CD38-, and CXCR-4+)

Page 40: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Highly differential expression of genes is primarily involved in

Growth factors /Extra cellular matrix molecules /Cell surface molecules /Receptors /

Suggest that the major difference between BM-MSCs and AD-MSCs : cell-cell interactions regulate or support tissue cells

Page 41: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

1. The tissue cells homing and mobilization.

CD106 (VCAM-1) / SDF-1 / MMP-9/HGF

Page 42: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Journal of Cellular biochem S 38:29-38 (2002)

BM-MSCs exppressed more key factors involved in Homing and mobilization of hematopoietic stem cells :CD106 / SDF-1 / MMP-9

Page 43: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Hematopoiesis LIF / SDF-1 / BMP-4 / Jagged-1 / HGF

AngiogenesisHGF / PIGF-1 / PIGF-2 / HB-EGF

2. The tissue cells supporting.

Page 44: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

3. The ECM remodeling properties

ECM remodeling protease MMP-1 / MMP-9

Page 45: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Our present study indicated the tissue specificity of mesenchymal stem cells exhists as analyzed by molecular characterization of their gene and protein expressions.

In addition to their cell surface phenotypic descriptions and multipotency examinations in vitro, this approach may be indispensable in further realizing the nature of tissue stem cell populations

Conclusions

Page 46: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Thanks for Your Attensions

Page 47: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 48: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Page 49: Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.

Proerythroblast

MultipotentStem Cell

Self-renewal ?

Early ActingSCF FL Tpo

G-CSFIL3IL6IL7

IL11

Erythrocyte Platelet Neutrophil Monocyte Eosinophil Basophil

Macrophage Mast Cell

Mega-karyocyte

Myeloblast MonoblastEosinophilicMonoblast

BasophilicMonoblast

CFU-ECFU-G CFU-M CFU-Eo CFU-Baso

BFU-E CFU-Mega CFU-GM

CFU-G, E, M, Mega

EpoIGF-1

EpoIGF-1

Tpo

G-CSFGM-CSF

SCF IL3GM-CSF

GM-CSFM-CSF

GM-CSFIL5

IL5

IL3IL4

IL3IL4

IL3IL4GM-CSF

M-CSF

SCFIL3GM-CSF

SCFIL3IL6Tpo

SCFIL3IL6G-CSFGM-CSF

GM-CSFM-CSF

The Haematopoietic System

• Humoral Regulation

ModulatingIL1IL4

MIP-1TNFTGF

CLPsCMPs